<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7806090</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6166</journal-id>
<journal-id journal-id-type="nlm-ta">Neurosci Biobehav Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci Biobehav Rev</journal-id>
<journal-title-group>
<journal-title>Neuroscience and biobehavioral reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0149-7634</issn>
<issn pub-type="epub">1873-7528</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28506922</article-id>
<article-id pub-id-type="pmc">5682229</article-id>
<article-id pub-id-type="doi">10.1016/j.neubiorev.2017.05.007</article-id>
<article-id pub-id-type="manuscript">VAPA880116</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bradley</surname>
<given-names>Ellen R.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Woolley</surname>
<given-names>Joshua D.</given-names>
</name>
</contrib>
<aff id="A1">Department of Psychiatry, University of California, San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Correspondence: Name: Ellen R. Bradley, <email>ellen.bradley@ucsf.edu</email>, Phone: (415) 476-7334, Mail: 4150 Clement St, San Francisco CA 94121</corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>Conflict of interest statement:</bold> The authors declare that they have no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>80</volume>
<fpage>36</fpage>
<lpage>56</lpage>
<!--elocation-id from pubmed: 10.1016/j.neubiorev.2017.05.007-->
<abstract>
<p id="P1">Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the extant literature and propose a focused agenda for future work that builds on the most compelling findings regarding oxytocin effects in schizophrenia to date. Specifically, we examine underlying causes of heterogeneity in randomized clinical trials (RCTs) conducted thus far and highlight the complexity of the human oxytocin system. We then review evidence of oxytocin's effects on specific deficits in schizophrenia, arguing for further study using objective, precise outcome measures in order to determine whether oxytocin has the potential to improve functional impairment in schizophrenia.</p>
</abstract>
<kwd-group>
<kwd>Oxytocin</kwd>
<kwd>schizophrenia</kwd>
<kwd>negative symptoms</kwd>
<kwd>social cognition</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>